← All indications
Desmoplastic Small Round Cell Tumor
A rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults. It is most commonly found in the abdomen.
Drugs by status
Phase 2 trials (32)
- prexasertib
- sorafenib
- irinotecan
- temsirolimus
- doxorubicin
- tacrolimus
- ramucirumab
- Filgrastim
- nivolumab
- lurbinectedin
- vitamin c
- vincristine
- ifosfamide
- ipilimumab
- cyclosporine
- mycophenolate
- cyclophosphamide
- temozolomide
- bevacizumab
- Anti-thymocyte Globulin (Rabbit)
- vinorelbine
- zoledronic acid
- masct:multiple antigens specific cellular therapy
- fludarabine
- thiotepa
- etoposide
- melphalan
- 131 i-omburtamab
- tislelizumab
- seclidemstat
- +2 more
Organizations
Organization Involved with Phase 2 Indications (25)
- Daiichi Sankyo
- Amgen
- Eli Lilly
- Novartis
- NantCell, Inc.
- National Cancer Institute (NCI)
- Cornell University
- Grupo Espanol de Investigacion en Sarcomas
- Oregon Health and Science University
- Situs Cancer Research Center
- Universidad Complutense de Madrid
- Thomas Jefferson University
- University of Florida
- University of Seville
- University of Tennessee
- University of Valencia
- Tel Aviv University
- City of Hope National Medical Center
- University of Texas at Houston
- University of Barcelona
- University of Zaragoza
- Y-Mabs, Inc
- Memorial Sloan-Kettering Cancer Center
- Hospital Universitario Niño Jesús
- St. Jude Children's Hospital
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)